Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/14—Hydrolases (3)
  • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
  • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
  • C12N9/2405—Glucanases
  • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
  • C12N9/2411—Amylases

Definitions

• the present invention relates to methods for producing new amylase enzymes using random mutation of DNA encoding for an amylase enzyme followed by isolation of amylase enzyme by evaluating the ability to hydrolyze starches in the presence of select cleaning composition ingredients.
• the present invention also relates to detergent compositions comprising a new amylase enzyme produced by the above method and cleaning composition ingredients.
• amylase enzymes have been used for a variety of different purposes, the most important of which are starch liquefaction, textile desizing, starch modification in the paper and pulp industry, and for brewing and baking.
• a further use of amylases. which is becoming increasingly important is the removal of starch-containing soils and stains during the washing of fabrics, hard surfaces and dishes.
• amylase enzymes have long been recognized in dishwashing, hard surface cleaning and laundry compositions to provide the removal of starchy food residues or starchy films from dishware, flatware, glasses and hard surfaces or to provide cleaning performance on starchy soils as well as other soils typically encountered in laundry applications.
• WO 94/02597 Novo Nordisk A/S published February 3, 1994, describes cleaning compositions which incorporate mutant amylases. See also WO 94/18314, Genencor, published August 18, 1994 and WO 95/10603, Novo Nordisk A/S, published April 20, 1995.
• amylases known for use in cleaning compositions include both ⁇ - and ⁇ -amylases.
• ⁇ -Amylases are known in the art and include those disclosed in U.S. Patent No. 5.003.257; EP 252,666; WO 91/00353; FR 2,676,456; EP 285,123; EP 525,610; EP 368,341 ; and British Patent Specification No. 1,296,839 (Novo).
• ⁇ -amylases products examples include Termanyl®, Ban®, Fungamyl®, and Duramyl®, all available from Novo Nordisk A S, Denmark. Recently, new amylases have been identified and are described in WO 95/26397, Novo Nordisk A/S, published October 5, 1995, disclosing an ⁇ -amylase having a specific activity at least 25% higher than the specific activity of Termamyl® at a temperature range of 25 to 55°C and at a pH value in the range of 8 to 10.
• amylase enzymes have already found utility in laundry and cleaning compositions. However, these enzymes still have there limitations when used in certain cleaning composition matrixes. Most product applications create a harsh environment for these enzymes, and common detergent ingredients such as builders and bleaches are likely to inactivate these enzymes. Thus, there continues to be a need to identify and isolate new amylase enzyme variants for use in cleaning compositions.
• amylases are typically the product of rational design wherein specific sites within known amylase enzymes are targeted for selected modification of the amino acid sequence, either by substituting a different amino acid for the existing one and/or by eliminating one amino acid or a portion of the enzyme chain.
• this approach can produce improved amylase enzymes, as evidenced by the above-noted publications and patents, but progress is slow and screening-intensive.
• these amylase enzymes may provide some benefits in cleaning product applications, but their activity is much reduced relative to their activity in their natural environment.
• Random mutagenesis the concept of using single-mutant libraries, and the technique of DNA shuffling (recombination) have been described previously, most recently in WO 97/09446, published March 13, 1997 by Novo Nordisk (random mutagenesis which uses a "catcher molecule” that binds specifically with - and then is used to separate - the enzyme variants that exhibit only the desired property).
• the number of amino acid mutations introduced per enzyme is limited by the screenable number of mutants; i.e. screening is limited by the numbers of possible variants.
• the number of possible sequences containing a given number of amino acid changes increases exponentially with the increasing number of changes.
• the number of possible variants containing all possible single amino acid changes is 5.7 x 10 ⁇ , for all possible double changes is -1.6 x 10 ', and for all possible triple changes is -3.1 x 10 ⁇ .
• the present invention also relates to detergent compositions comprising novel amylases having increased hydrolytic activity and detergent composition ingredients.
• error-prone PCR polymerase chain reaction
• WO 94/02597 Novo Nordisk A/S published February 3, 1994, describes cleaning compositions which incorporate mutant amylases. See also WO 94/18314, Genencor, published August 18, 1994 and WO 95/10603, Novo Nordisk A/S, published April 20, 1995.
• Other amylases known for use in cleaning compositions include those disclosed in U.S. Patent No. 5,003,257; EP 252,666; WO 91/00353; FR 2,676,456; EP 285,123; EP 525,610; EP 368,341; and British Patent Specification No. 1,296,839 (Novo).
• the present invention relates to a method for producing DNA for new amylase enzymes useful for cleaning applications. This method comprises:
• step (b) incorporating the mutated DNA from step (a) into a microorganism which is capable of expressing amylase enzyme
• step (c) separating into individual isolates organisms from step (b) such that a minimum number (preferably on average about one) of the organisms containing mutated DNA is present in each isolate;
• step (g) optionally repeating, one or more times, steps (a) to (f) and then collecting the mutated DNA.
• the present invention also relates to a method for producing organisms which produce amylase enzymes useful for cleaning applications. This method comprises:
• step (a) randomly mutating, by chemical and/or enzymatic mean, single or double site mutations in one or more DNA encoding for an amylase enzyme; (b) incorporating the mutated DNA from step (a) into a microorganism which is capable of expressing amylase enzyme;
• step (c) separating into individual isolates organisms from step (b) such that a minimum number (preferably on average about one) of the organisms containing mutated DNA is present in each isolate;
• step (g) optionally repeating, one or more times, steps (a) to (f) and then collecting the organisms containing mutated DNA that produce the amylase.
• the present invention also relates to detergent compositions comprising:
• the process of generating random mutations in genes for the present invention methods is accomplished by any method which randomly produces only one or two changes (on average) per DNA strand.
• a preferred process of generating such random mutations is using "error prone” polymerase chain reaction ("error-prone PCR") as described in detail by Leung et al. (Technique 1 : 1 1-15; 1989) and Cadwell & Joyce (PCR Methods Applic. 2:28-33; 1992).
• error-prone PCR polymerase chain reaction
• the gene or gene fragment of interest is excised from a plasmid vector that has been engineered to contain the appropriate restriction enzyme site.
• the fragment is mutagenized by error-prone PCR, and the population of mutant DNA molecules restricted with the appropriate enzymes and ligated back into the original plasmid vector to generate a mutant "library", for example as shown in the Leung et al. article
• the overall error rate of the "error-prone" PCR process must be adjusted so that the average number of mutations in the population at the amino acid (protein) level is one. Because of the redundancy of the genetic code, this translates to an average of approximately two mutations at the DNA level in the variant gene library.
• the error rate may be adjusted, for example, by altering the manganese concentration in the PCR reaction (see, for example, the reaction conditions described in the Cadwell & Joyce article noted above). This must be done for each gene to be mutated at the beginning of the process. Additional details regarding the use of error-prone PCR are found in WO 95/22625, published August 24, 1995 by Affymax Technologies N.V., incorporated by reference herein in its entirety.
• the DNA selected for this random mutation step may be any DNA which encodes for an ⁇ -amylase protein. However, it is preferred herein to use the DNA which encodes for known ⁇ - amylases which have been evaluated for use in cleaning compositions. Such amylase enzymes include those described in WO 95/26397.
• ⁇ -amylases characterized by having a specific activity at least 25% higher than the specific activity of Termamyl® at a temperature range of 25°C to 55°C and at a pH value in the range of 8 to 10, measured by the Phadebas® ⁇ -amylase ⁇ activity assay, as described in detail in WO 95/26397.
• ⁇ -amylases according to (a) comprising the amino sequence shown in SEQ ID No. 1 or an ⁇ - amylase being at least 80% homologous with the amino acid sequence shown in SEQ ID No. 1.
• a peptide is considered to be X% homologous to the parent amylase if a comparison of the respective amino acid sequences, performed via algorithms, such as the one described by Lipman and Pearson in Science 227, 1985, p. 1435, reveals an identity of X%.
• ⁇ -amylases according to (a or b) wherein the ⁇ -amylase is obtainable from an alkalophilic Bacillus species; and in particular, from any of the strains NCIB 12289, NCIB 12512, NCIB 12513 and DSM 935.
• the term "obtainable from” is intended not only to indicate an amylase produced by a Bacillus strain but also an amylase encoded by a DNA sequence isolated from such a Bacillus strain and produced in a host organism transformed with said DNA sequence.
• Amylases showing positive immunological cross-reactivity with antibodies raised against an ⁇ - amylase having an amino acid sequence corresponding to SEQ ID No. 1, or Termamyl.
• Variants of the following parent ⁇ -amylases which (i) have the amino acid sequence shown in SEQ ID No. 1, or (ii) displays at least 60 %, preferably 80%, homology with this amino acid sequence, and/or displays immunological cross-reactivity with an antibody raised against an ⁇ - amylase having this amino acid sequence, and/or is encoded by a DNA sequence which hybridizes with the same probe as a DNA sequence encoding an ⁇ -amylase having this amino acid sequence; in which variants:
• At least one amino acid residue of said parent ⁇ -amylase has been replaced by a different amino acid residue
• At least one amino acid residue has been inserted relative to said parent ⁇ -amylase; said variant having an ⁇ -amylase activity and exhibiting at least one of the following properties relative to said parent ⁇ -amylase: increased thermostability, increased stability towards oxidation, reduced Ca ion dependency, increased stability and/or ⁇ -amylolytic activity at neutral to relatively high pH values, increased ⁇ -amylolytic activity at relatively high temperature and increase or decrease of the isoelectric point (pi) so as to better match the pi value for ⁇ -amylase variant to the pH of the medium.
• B Incorporation of Mutated DNA into Microorganisms Capable of Expressing Amylase
• the population of mutated DNA molecules (as described herein before, averaging about 1 amino acid change in the final protein product), cloned in an appropriate plasmid DNA vector, be introduced into a standard, commercially available E. coli strain (such as XL-2 Blue from Stratagene), using a standard DNA transformation method, followed by isolation of resulting transformants on agar plates (all standard methods).
• the transformation method is such that each isolated colony that grows on the agar plate has resulted from a single, transformed cell containing a single, mutated amylase gene DNA sequence. These colonies are pooled together and the plasmid DNAs they contain are isolated, to give a population of plasmid DNA molecules representative of the entire orginal (from the random mutation step hereinbefore) population of mutated DNA molecules.
• this preferred step is to amplify the amount of the population of the original, mutated DNA molecules, since transformation directly into Bacillus species is generally difficult with small amounts of DNA (thus it is preferred to use this intermediate E. coli step as an amplification step; no amylase is produced at this stage since E. coli is not capable of producing it).
• the mutated DNA molecules from the random mutation step are introduced into an organism capable of producing amylase enzymes (preferably for the present process a Bacillus species) using a standard DNA transformation method.
• the cells useful in this invention may be a cell of a higher organism such as a mammal or an insect, but is preferably a microbial cell, e.g., a bacterial or a fungal (including yeast) cell.
• a microbial cell e.g., a bacterial or a fungal (including yeast) cell.
• suitable bacteria are gram positive bacteria such as Bacillus subtilis. Bacillus licheniformis. Bacillus lentus. Bacillus brevis. Bacillus stearothermophilus. Bacillus alkalophilus. Bacillus amyloliquefaciens. Bacillus coaqulans. Bacillus circulans. Bacillus lautus. Bacillus megaterium. Bacillus thuringiensis. Streptomyces lividans or Streptomyces murinus. or gram negative bacteria such as E. coli.
• the transformation of the bacteria may, for instance, be effected by protoplast transformation or by using competent cells in a manner known per se.
• the yeast organism may favorably be selected from a species of Saccharomyces or Schizosaccharomyces. e.g., Saccharomyces cerevisiae.
• the filamentous fungus may advantageously belong to a species of Aspergillus. e.g., Aspergillus oryzae or Aspergillus niger.
• Fungal cells may be transformed by a process involving protoplast formation and transformation of the protoplasts followed by regeneration of the * ⁇ cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238,023.
• Preferred ⁇ -amylases of the invention are obtainable from an alkaliphilic Bacillus species, particularly from one of the Bacillus strains NCIB 12289, NCIB 12512, NCIB 12513 and DSM 9375.
• the term "obtainable from” is intended not only to indicate an ⁇ -amylase produced by a Bacillus strain but also an ⁇ -amylase encoded by a DNA sequence isolated from such a Bacillus strain, modified by the present invention process, and produced in a host organism transformed with this mutated DNA sequence.
• the strain NCIB 12289 is described in detail in EP 277,216.
• the strain NCIB 12289 has been deposited according to the Budapest Treaty on the International Recognition of the Deposits of Microorganisms for the Purpose of Patent Procedures, on July 8, 1996 at The National Collection of Industrial Bacteria (NCIB) under accession No. NCIB 12289.
• the strain NCIB 12512 is described in detail in EP 277,216.
• the strain NCIB 12512 has been deposited according to the Budapest Treaty on the International Recognition of the Deposits of Microorganisms for the Purpose of Patent Procedures, on August 5, 1987 at The National Collection of Industrial Bacteria (NCI) under accession No. NCIB 12512.
• the strain NCIB 12513 is described in detail in EP 277,216.
• the strain NCIB 12513 has been deposited according to the Budapest Treaty on the International Recognition of the Deposits of Microorganisms for the Purpose of Patent Procedures, on August 5, 1987 at The National Collection of Industrial Bacteria (NCIB) under accession No. NCIB 12513.
• strain DSM 9375 has been deposited according to the Budapest Treaty on the International Recognition of the Deposits of Microorganisms for the Purpose of Patent Procedures, on August 16, 1994 at Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSM) under Accession No. DSM 9375.
• an ⁇ -amylase-encoding DNA sequence produced by methods described above can be expressed, in enzyme form, using an expression vector which typically includes control sequences encoding a promoter, operator, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes.
• the recombinant expression vector carrying the DNA sequence encoding an ⁇ -amylase produced by the present invention method may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced.
• the vector may be an autonomously replicating vector, i.e. a vector which exists as an extra chromosomal entity, the replication of which is independent of chormosomal replication, e.g., a plasmid, a bacteriophage or an extra chromosomal element, minichromosome or an artificial chromosome.
• the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome(s) into which it has been integrated.
• the DNA sequence should be operably connected to a suitable promoter sequence.
• the promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
• suitable promoters for directing the transcription of the DNA sequence encoding an ⁇ -amylase, especially in a bacterial host are the promoter of the ]ac operon of E. coli.
• the Streptomyces coelicolor agarase gene dagA promoters the promoters of the Bacillus licheniformis ⁇ -amylase gene (amyL).
• promoters of the Bacillus Amyloliquefaciens ⁇ -amylase (amyO). the promoters of the Bacillus subtilis xylA and xylB genes, etc.
• useful promoters are those derived from the gene encoding A. oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, A. niger neutral ⁇ -amylase, A. niger acid stable ⁇ -amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase.
• the expression vector may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the desired ⁇ -amylase. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
• the vector may further comprise a DNA sequence enabling the vector to replicate in the host cell in question.
• a DNA sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUBl 10, pE194, pAMBl and pIJ702.
• the vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the host cell such as the dal genes from B. subtilis or B. licheniformis. or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
• a selectable marker e.g., a gene the product of which complements a defect in the host cell such as the dal genes from B. subtilis or B. licheniformis. or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
• the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and sC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, e.g., as described in WO 91/17243.
• intracellular expression may be advantageous in some respects, e.g., when using certain bacteria as host cells, it is generally preferred that the expression is extracellular.
• the resulting transformants from the proceeding steps containing the large amount of DNA produced by the random mutation step herein above, and which has been transformed (using standard methods, for example those described in "Biology of Bacilli: Applications to Industry", 1992, R.H. Doi and M. McGloughlin, Editors, Butterworth-Heinemann, Stoneham, MA., pp. 357- 359) into the appropriate species (e.g., preferably Bacillus species), are isolated on agar plates using standard methods. At this stage, for example, the individual Bacillus colonies that have derived from single, transformed cells containing single, mutated amylase gene DNA sequences, are able to express the amylase gene (i.e. make variant amylase proteins).
• the medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the ⁇ -amylase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published recipes (e.g., as described in catalogues of the American Type Culture Collection).
• the ⁇ -amylase secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
• a salt such as ammonium sulphate
• the present invention process produces an ⁇ -amylase having an activity at least 25% higher (preferably at least 35% higher, more preferably at least 50% higher, and most preferably at least 75% ⁇ higher) than the activity of the parent amylase from which the DNA was obtained and mutated by the random mutation step of this process (preferably at a temperature in the range of 25°C to 55°C).
• amylases produced by the present methods which not only have a specific activity at least 25% greater than the parent amylase from which the DNA was obtained from the random mutation step, but further this amylase has a specific activity at least 25% greater than the commercially available amylase Teramamyl®.
• Phadebas® tablets Phhadebas® Amylase Test, supplied by Pharmacia Diagnostic
• Phadebas tablets contain a cross-linked insoluble blue-colored starch polymer which has been mixed with bovine serum albumin and a buffer substance and tableted.
• Phadebas tablet is added to 6 ml of detergent solution and vortexed for 15 seconds.
• the Phadebas suspension containing cleaning composition ingredients comprising at least surfactant and/or builder and/or bleaching agents as described in detail herein after, is added to each well in a 96-well plate.
• the suspension contain a fully formulated detergent composition, comprising surfactant and builder, and also preferably one or more ingredients selected from bleaching agents, detergent polymers, and/or chelants, as described in greater detail hereinafter.
• 20 ⁇ l of enzyme which is the supernatant from the cell growth described herein before is added and incubated for 15 min. 1 ml of NaOH is added after 15 min of incubation and vortexed for 15 sec. The reaction solution is then filtered.
• the starch which is hydrolyzed by the alpha-amylase, gives soluble blue fragments and the absorbance of the resulting blue solution is measured spectrophotometrically at 620 nm. It is important that the measured absorbance is at 620 nm range in the 0.2-2.0 absorbance units to maintain the linearity between activity and absorbance.
• the reaction solutions must be diluted to have absorbance in this region. Higher absorbance readings is indicative of higher amylolytic activity under the specified conditions of the reaction.
• kinetic assay can be performed instead of taking measurements at a given time by measuring absorbances at several time intervals. The above protocol must be followed for each time interval. The slope of the curve of the new libraries vs. the slope of the parent amylase is compared to assess increased amylolytic activity.
• a specific procedure to screen the improved amylase in a Loprodyne "Silent Monitor" 96- well assay plates (Pall Biosupport) for development in granular detergents is described as follows.
• a wash solution is prepared in 6 gpg hardness (3:1 CaCl2:MgCl2) with 0.07 ppm of an amylase with Sequence No. 1 and 1 g/L of the following detergent composition.
• the pH of above solution is adjusted to approximately 10.5. 5 mis of this solution is added to 20 mis of de-ionized water.
• the Phadebas solution is prepared by adding 1 Phadebas tablet in 5 mis of de-ionized water. Phadebas tablets are from Pharmacia and Upjohn (manufactured in Sweden, distributed by Pharmacia Diagnostics Div. of Electro-Nucleonics, Inc. Fairfield, New Jersey). After mixing the Phadebas solution, 143 ⁇ l is added into each well of the 96 well plate. To each well, containing the Phadebas solution, 29 ⁇ l of diluted wash solution is added. The reaction is progressed for 20 minutes and stopped via addition of 29 ⁇ l IM NaOH per well. The contents of the loprodyne plate is filtered using a Pall vacuum manifold into a clean 96- well Dynatech plate. The concentration of liberated dye in the filtrate is read at 620 nm.
• An amylase of this invention delivers at least 25% increased Phadebas hydrolysis versus the amylase having SEQ. ID No. 1 dosed at 0.07 ppm protein at 25°C in the presence of the cleaning composition ingredients.
• the DNA sequence encoding an ⁇ -amylase produced by the present invention process may be isolated from any cell or microorganism producing the ⁇ -amylase in question, using various methods well known in the art.
• cells from wells on the 96-well plates that generated supernatants having a positive result (by demonstrating improved amylolytic activity as described hereinbefore) are then isolated and, preferably re-screened (i.e., inoculation into 96-well plates; growth; re-assay) to confirm that the variant amylases they are producing are indeed improved.
• These cells from individual wells on the 96-well plated are then grown up (separately) in a larger scale, and the plasmid DNA isolated from them using standard methods.
• These DNAs (each DNA preparation represents a single amylase variant) can then be used in subsequent rounds of mutagenesis and screening (preferably, only one or two of the DNAs representing the best results are used as the starting points for the next cycle of mutagenesis
• these positive DNAs can be recombined by DNA shuffling (as described herein after) to make all possible combinations of the positive mutations.
• DNA shuffling the resultant combinations are introduced into E.coli, then Bacillus, and the resultant cells screened to potentially identify "better positives", in the same way as described hereinbefore.
• the best positive variant from the DNA shuffling step can then either be taken as the end result, or itself used as the starting point for the next cycle of mutagenesis (with or without shuffling).
• DNA shuffling is a method for recombining unique, but homologeous DNA sequences, whereby all possible combinations of each unique sequence can be generated.
• sequences of interest e.g., gene fragments, as described above
• assembly PCR reaction where single-stranded pieces of different variants can prime each other
• DNA shuffling is optional, it is a highly preferred optional part of the present invention process, since it allows all possible combinations of positive variants isolated from screening of mutagenic libraries to be constructed rapidly, and tested.
• the detergent compositions of the invention contain cleaning composition ingedients as described hereinafter.
• the precise nature of these components, and levels of incorporation thereof will depend on the physical form of the ⁇ composition, and the nature of the cleaning operation for which it is to be used.
• the detergent compositions according to the invention can be liquid, paste, gels, bars, tablets, powder or granular forms.
• Granular compositions can also be in "compact” form, the liquid compositions can also be in a "concentrated” form.
• compositions of the invention may for example, be formulated as hand and machine laundry detergent compositions including laundry additive compositions and compositions suitable for use in the soaking and/or pretreatment of stained fabrics, rinse added fabric softener compositions. Pre-or post treatment of fabric include gel, spray and liquid fabric conditioning compositions.
• the compositions of the invention preferably contain both a surfactant and a builder compound and additionally one or more detergent components preferably selected from organic polymeric compounds, bleaching agents, additional enzymes, suds suppressors, dispersants, lime-soap dispersants, soil suspension and anti-redeposition agents and corrosion inhibitors.
• Laundry compositions can also contain softening agents, as additional detergent components.
• compositions of the invention can also be used as detergent additive products. Such additive products are intended to supplement or boost the performance of conventional detergent compositions.
• the density of the laundry detergent compositions herein ranges from 400 to 1200 g/litre, preferably 600 to 950 g/litre of composition measured at 20°C.
• compositions herein are best reflected by density and, in terms of composition, by the amount of inorganic filler salt; inorganic filler salts are conventional ingredients of detergent compositions in powder form; in conventional detergent compositions, the filler salts are present in substantial amounts, typically 17-35% by weight of the total composition.
• the filler salt is present in amounts not exceeding 15% of the total composition, preferably not exceeding 10%, most preferably not exceeding 5% by weight of the composition.
• the inorganic filler salts are selected from the alkali and alkaline-earth-metal salts of sulphates and chlorides.
• a preferred filler salt is sodium sulphate.
• Liquid detergent compositions according to the present invention can also be in a "concentrated form", in such case, the liquid detergent compositions according the present invention will contain a lower amount of water, compared to conventional liquid detergents.
• the water content of the concentrated liquid detergent is preferably less than 40%, more preferably less than 30%, most preferably less than 20% by weight of the detergent composition.
• the detergent compositions according to the present invention comprise a surfactant or surfactant system wherein the surfactant can be selected from nonionic and/or anionic and/or cationic surfactants and/or ampholytic and/or zwitterionic and/or semi-polar nonionic surfactants.
• the surfactant is typically present at a level of from about 0.1 %, more preferably about 1% by weight of the deteregent compositions to about 60%, more preferably about 35%, most preferably 30% about by weight of the detergent compositions.
• the surfactant is preferably formulated to be compatible with enzyme components present in the composition.
• the surfactant is most preferably formulated such that it promotes, or at least does not degrade, the stability of any enzyme in these compositions.
• nonionic, anionic, cationic, ampholytic, zwitterionic and semi- polar nonionic surfactants are disclosed in U.S. Patent Nos. 5,707,950 and 5,576,282.
• Nonionic surfactants are polyhydroxy fatty acid amide surfactants of the formula:
• R 2 - C(0) - N(R!) - Z, wherein R* is H, or R* is C 1.4 hydrocarbyl, 2-hydroxy ethyl, 2-hydroxy propyl or a mixture thereof, R 2 is C5.31 hydrocarbyl, and Z is a polyhydroxyhydrocarbyl having a linear hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain, or an alkoxylated derivative thereof.
• R! is methyl
• R 2 is a straight Cu.15 alkyl or C j g.
• j g alkyl or alkenyl chain such as coconut alkyl or mixtures thereof
• Z is derived from a reducing sugar such as glucose, fructose, maltose, lactose, in a reductive amination reaction.
• alkyl alkoxylated sulfate surfactants hereof are water soluble salts or acids of the formula RO(A) m S03M wherein R is an unsubstituted C10-C24 alkyl or hydroxyalkyl group having a C10-C24 alkyl component, preferably a C12-C20 alkyl or hydroxyalkyl, more preferably C ⁇ -Cj g alkyl or hydroxyalkyl, A is an ethoxy or propoxy unit, m is greater than zero, typically between about 0.5 and about 6, more preferably between about 0.5 and about 3, and M is H or a catjon which can be, for example, a metal cation (e.g., sodium, potassium, lithium, calcium, magnesium, etc.), ammonium or substituted- ammonium cation. Alkyl ethoxylated sulfates as well as alkyl propoxylated sulfates are contemplated herein.
• the laundry detergent compositions of the present invention typically comprise from about 1%, more preferably about 3% by weight of such such anionic surfactants to about 40%, more preferably about 20% by weight of such anionic surfactants.
• Highly preferred cationic surfactants are the water-soluble quaternary ammonium compounds useful in the present composition having the formula :
• the detergent compositions of the present invention typically comprise from about 0.2%, more preferably about 1% by weight of such cationic surfactants to about 25%, more preferably about 8% by weight of such cationic surfactants.
• the detergent compositions of the present invention typically comprise from about 0.2%, more preferably about 1 % by weight of such ampholytic surfactants to about 15%, more preferably about 10% by weight of such ampholytic surfactants.
• the detergent compositions of the present invention typically comprise from about 0.2%, more preferably about 1% by weight of such zwitterionic surfactants to about 15%), more preferably about 10% by weight of such zwitterionic surfactants.
• the detergent compositions of the present invention typically comprise from about 0.2%, more preferably 1% by weight of such semi-polar nonionic surfactants to about 15%, more preferably about 10% by weight of such semi-polar nonionic surfactants.
• the detergent compositions of the present invention can also comprise from about 0.001% to about 100% of one or more (preferably a mixture of two or more) mid-chain branched surfactants, preferably mid-chain branched alkyl alkoxy alcohols having the formula:
• M is a water soluble cation and may comprises more than one type of cation, for example, a mixture of sodium and potassium.
• the index w is an integer from 0 to 13; x is an integer from 0 to 13; y is an integer from 0 to 13; z is an integer of at least
• EO and PO represent ethyleneoxy units and propyleneoxy units having the formula:
• alkoxy units inter alia 1,3 -propyleneoxy, butoxy, and mixtures thereof are suitable as alkoxy units appended to the mid-chain branched alkyl moieties.
• the mid-chain branched surfactants are preferably mixtures which comprise a surfactant system. Therefore, when the surfactant system comprises an alkoxylated surfactant, the index m indicates the average degree of alkoxy lation within the mixture of surfactants. As such, the index m is at least about 0.01, preferably within the range of from about 0.1, more preferably from about 0.5, most preferably from about 1 to about 30, preferably to about 10, more preferably to about 5.
• the value of the index m represents a distribution of the average degree of alkoxylation corresponding to m, or it may be a single specific chain with alkoxylation (e.g., ethoxylation and/or propoxylation) of exactly the number of units corresponding to m.
• the preferred mid-chain branched surfactants of the present invention which are suitable for use in the surfactant systems of the present invention have the formula:
• the surfactant systems of the present invention which comprise mid-chain branched surfactants are preferably formulated in two embodiments.
• a first preferred embodiment comprises mid-chain branched surfactants which are formed from a feedstock which comprises 25% or less of mid-chain branched alkyl units. Therefore, prior to admixture with any other conventional surfactants, the mid-chain branched surfactant component will comprise 25% or less of surfactant molecules which are non-linear surfactants.
• a second preferred embodiment comprises mid-chain branched surfactants which are formed from a feedstock which comprises from about 25% to about 70% of mid-chain branched alkyl units. Therefore, prior to admixture with any other conventional surfactants, the mid-chain branched surfactant component will comprise from about 25% to about 70% surfactant molecules which are non-linear surfactants.
• the surfactant systems of the laundry detergent compositions of the present invention can also comprise from about 0.001%), preferably from about 1%, more preferably from about 5%, most preferably from about 10% to about 100%, preferably to about 60%), more preferably to about 30% by weight, of the surfactant system, of one or more (preferably a mixture of two or more) mid-chain branched alkyl arylsulfonate surfactants, preferably surfactants wherein the aryl unit is a benzene ring having the formula:
• L is an acyclic hydrocarbyl moiety comprising from 6 to 18 carbon atoms
• R 1 , R 2 , and R 3 are each independently hydrogen or C C 3 alkyl, provided R 1 and R 2 are not attached at the terminus of the L unit
• M is a water soluble cation having charge q wherein a and b are taken together to satisfy charge neutrality.
• compositions of the present invention preferably comprise a bleaching system.
• Bleaching systems typically comprise a “bleaching agent” (source of hydrogen peroxide) and an “initiator” or “catalyst".
• bleaching agents will typically be at levels of from about 1%, preferably from about 5% to about 30%, preferably to about 20% by weight of the composition.
• the amount of bleach activator will typically be from about 0.1%, preferably from about 0.5% to about 60%, preferably to about 40% by weight, of the bleaching composition comprising the bleaching agent-plus-bleach activator.
• Bleaching Agents Hydrogen peroxide sources are described in detail in the herein incorporated Kirk Othmer's Encyclopedia of Chemical Technology, 4th Ed (1992, John Wiley & Sons), Vol. 4, pp. 271-300 "Bleaching Agents (Survey)", and include the various forms of sodium perborate and sodium percarbonate, including various coated and modified forms.
• the preferred source of hydrogen peroxide used herein can be any convenient source, including hydrogen peroxide itself.
• perborate e.g., sodium perborate (any hydrate but preferably the mono- or tetra-hydrate), sodium carbonate peroxyhydrate or equivalent percarbonate salts, sodium pyrophosphate peroxyhydrate, urea peroxyhydrate, or sodium peroxide
• sources of available oxygen such as persulfate bleach (e.g., OXONE, manufactured by DuPont).
• Sodium perborate monohydrate and sodium percarbonate are particularly preferred. Mixtures of any convenient hydrogen peroxide sources can also be used.
• a preferred percarbonate bleach comprises dry particles having an average particle size in the range from about 500 micrometers to about 1,000 micrometers, not more than about 10% by weight of said particles being smaller than about 200 micrometers and not more than about 10% by weight of said particles being larger than about 1,250 micrometers.
• the percarbonate can be coated with a silicate, borate or water-soluble surfactants.
• Percarbonate is available from various commercial sources such as FMC, Solvay and Tokai Denka.
• compositions of the present invention may also comprise as the bleaching agent a chlorine-type bleaching material.
• a chlorine-type bleaching material such agents are well known in the art, and include for example sodium dichloroisocyanurate (“NaDCC").
• NaDCC sodium dichloroisocyanurate
• chlorine-type bleaches are less preferred for compositions which comprise enzymes.
• the peroxygen bleach component in the composition is formulated with an activator (peracid precursor).
• the activator is present at levels of from about 0.01%, preferably from about 0.5%, more preferably from about 1% to about 15%, preferably to about 10%, more preferably to about 8%, by weight of the composition.
• Preferred activators are selected from the group consisting of tetraacetyl ethylene diamine (TAED), benzoylcaprolactam (BzCL), 4-nitrobenzoylcaprolactam, 3-chlorobenzoybaprolactam, benzoyloxybenzenesulphonate (BOBS), nonanoyloxybenzenesulphonate (NOBS), phenyl benzoate (PhBz), decanoyloxybenzenesulphonate (CI Q-OBS), benzoylvalerolactam (BZVL), octanoyloxybenzenesulphonate (Cg-OBS), perhydrolyzable esters and mixtures thereof, most preferably benzoylcaprolactam and benzoylvalerolactam.
• Particularly preferred bleach activators in the pH range from about 8 to about 9.5 are those selected having an OBS or VL leaving group.
• Preferred hydrophobic bleach activators include, but are not limited to, nonanoyloxybenzenesulphonate (NOBS), 4-[N-(nonaoyl) amino hexanoyloxy] -benzene sulfonate sodium salt (NACA-OBS) an example of which is described in U.S. Patent No. 5,523,434, lauryloxybenzenesulphonate (LOBS or C 12 -OBS), 10- undecenoyloxybenzenesulfonate (UDOBS or Cj ]-OBS with unsaturation in the 10 position), and decanoyloxybenzoic acid (DOBA).
• NOBS nonanoyloxybenzenesulphonate
• NACA-OBS 4-[N-(nonaoyl) amino hexanoyloxy] -benzene sulfonate sodium salt
• LOBS or C 12 -OBS lauryloxybenzenesulphonate
• Preferred bleach activators are those described in U.S. 5,698,504 Christie et al., issued December 16, 1997; U.S. 5,695,679 Christie et al. issued December 9, 1997; U.S. 5,686,401 Willey et al., issued November 1 1, 1997; U.S. 5,686,014 Hartshorn et al., issued November 1 1, 1997; U.S. 5,405,412 Willey et al., issued April 11, 1995; U.S. 5,405,413 Willey et al., issued April 1 1, 1995; U.S. 5,130,045 Mitchel et al., issued July 14, 1992; and U.S. 4,412,934 Chung et al., issued November 1, 1983, and copending patent applications U. S. Serial Nos. 08/709,072, 08/064,564, all of which are incorporated herein by reference.
• the mole ratio of peroxygen bleaching compound (as AvO) to bleach activator in the present invention generally ranges from at least 1 : 1, preferably from about 20: 1, more preferably from about 10: 1 to about 1 : 1, preferably to about 3: 1.
• Quaternary substituted bleach activators may also be included.
• the present detergent compositions preferably comprise a quaternary substituted bleach activator (QSBA) or a quaternary substituted peracid (QSP); more preferably, the former.
• QSBA quaternary substituted bleach activator
• QSP quaternary substituted peracid
• Preferred QSBA structures are further described in U.S. 5,686,015 Willey et al., issued November 1 1, 1997; U.S. 5,654,421 Taylor et al., issued August 5, 1997; U.S. 5,460,747 Gosselink et al., issued October 24, 1995; U.S. 5,584,888 Miracle et al., issued December 17, 1996; and U.S. 5,578,136 Taylor et al., issued November 26, 1996; all of which are incorporated herein by reference.
• bleach activators useful herein are amide-substituted as described in U.S. 5,698,504, U.S. 5,695,679, and U.S. 5,686,014 each of which are cited herein above.
• Preferred examples of such bleach activators include: (6-octanamidocaproyl) oxybenzenesulfonate, (6-nonanamidocaproyl)oxybenzenesulfonate, (6-decanamidocaproyl)oxybenzenesulfonate and mixtures thereof.
• bleaching results can be obtained from bleaching systems having with in-use pH of from about 6 to about 13, preferably from about 9.0 to about 10.5.
• activators with electron- withdrawing moieties are used for near-neutral or sub-neutral pH ranges.
• Alkalis and buffering agents can be used to secure such pH.
• Acyl lactam activators as described in U.S. 5,698,504, U.S. 5,695,679 and U.S. 5,686,014, each of which is cited herein above, are very useful herein, especially the acyl caprolactams (see for example WO 94-28102 A) and acyl valerolactams (see U.S. 5,503,639 Willey et al., issued April 2, 1996 incorporated herein by reference).
• compositions and methods utilize metal-containing bleach catalysts that are effective for use in cleaning compositions.
• metal-containing bleach catalysts that are effective for use in cleaning compositions.
• Preferred are manganese and cobalt-containing bleach catalysts.
• One type of metal-containing bleach catalyst is a catalyst system comprising a transition metal cation of defined bleach catalytic activity, such as copper, iron, titanium, ruthenium tungsten, molybdenum, or manganese cations, an auxiliary metal cation having little or no bleach catalytic activity, such as zinc or aluminum cations, and a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly ethylenediaminetetraacetic acid, ethylenediaminetetra (methylenephosphonic acid) and water- soluble salts thereof.
• a transition metal cation of defined bleach catalytic activity such as copper, iron, titanium, ruthenium tungsten, molybdenum, or manganese cations
• an auxiliary metal cation having little or no bleach catalytic activity such as zinc or aluminum cations
• a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly ethylenediaminetetraacetic
• compositions herein can be catalyzed by means of a manganese compound.
• a manganese compound Such compounds and levels of use are well known in the art and include, for example, the manganese-based catalysts disclosed in U.S. 5,576,282 Miracle et al., issued November 19, 1996; U.S. 5,246,621 Favre et al., issued September 21, 1993; U.S. 5,244,594 Favre et al., issued September 14, 1993; U.S. 5,194,416 Jureller et al., issued March 16, 1993; U.S. 5,114,606 van Vliet et al., issued May 19, 1992; and European Pat. App. Pub. Nos.
• Preferred examples of these catalysts include Mn 1 V 2(u-0)3 ( 1 ,4,7-trimethyl- 1 ,4,7-triazacyclononane)2(PF6)2, Mn ⁇ i 2(u-0) j (u-OAc) 2 ( 1 ,4,7- trimethyl- 1 ,4,7-triazacyclononane)2(C104)2, Mn ⁇ 4(u-O)g( 1 ,4,7-triazacyclononane)4(C104)4, Mn ⁇ Mn IV 4 (u-0) (u-OAc) 2 .( 1 ,4,7-trimethyl- 1 ,4,7-triazacyclononane)2(C104)3, Mn 1 v ( 1 ,4,7- trimethyl- 1 ,4,7-triazacyclononane)- (OCH3)3(PFg), and mixtures thereof.
• metal-based bleach catalysts include those disclosed in U.S. 4,430,243 included by reference herein above and U.S. 5,1 14,61 1 van Kralingen, issued May 19, 1992.
• the use of manganese with various complex ligands to enhance bleaching is also reported in the following: U.S. 4,728,455 Rerek, issued March 1, 1988; U.S. 5,284,944 Madison, issued Februaary 8, 1994; U.S. 5,246,612 van Dijk et al., issued September 21, 1993; U.S. 5,256,779 Kerschner et al., issued October 26, 2993; U.S. 5,280,1 17 Kerschner et al., issued January 18, 1994; U.S.
• Cobalt bleach catalysts useful herein are known, and are described, for example, in U.S. 5,597,936 Perkins et al., issued January 28, 1997; U.S. 5,595,967 Miracle et al., January 21, 1997; U.S. 5,703,030 Perkins et al., issued December 30, 1997; and M. L. Tobe, "Base Hydrolysis of Transition-Metal Complexes". Adv. Inorg. Bioinorg. Mech.. (1983), 2, pages 1-94.
• cobalt pentaamine acetate salts having the formula [Co(NH3)5 ⁇ Ac] T v , wherein "OAc” represents an acetate moiety and “Ty” is an anion, and especially cobalt pentaamine acetate chloride, [Co(NH3)5 ⁇ Ac]Cl2; as well as [Co(NH 3 ) 5 OAc](OAc)2; [Co(NH 3 ) 5 OAc](PF 6 ) 2 ; [Co(NH 3 )5 ⁇ Ac](SO 4 ); [Co. (NH 3 ) 5 OAc](BF 4 )2; and [Co(NH 3 ) 5 OAc](N ⁇ 3)2 (herein "PAC").
• Transition Metal Complexes of Macropolycyclic Rigid Ligands - Compositions herein may also suitably include as bleach catalyst a transition metal complex of a macropolycyclic rigid ligand.
• the phrase "macropolycyclic rigid ligand” is sometimes abbreviated as "MRL” in discussion below.
• the amount used is a catalytically effective amount, suitably about 1 ppb or more, for example up to about 99.9%, more typically about 0.001 ppm or more, preferably from about 0.05 ppm to about 500 ppm (wherein "ppb” denotes parts per billion by weight and "ppm” denotes parts per million by weight).
• Suitable transition metals e.g., Mn are illustrated hereinafter.
• Macropolycyclic means a MRL is both a macrocycle and is polycyclic.
• Polycyclic means at least bicyclic.
• the term “rigid” as used herein herein includes “having a superstructure” and “cross-bridged”. "Rigid” has been defined as the constrained converse of flexibility: see D.H. Busch., Chemical Reviews.. (1993), 21, 847-860, incorporated by reference.
• rigid as used herein means that the MRL must be determinably more rigid than a macrocycle ("parent macrocycle") which is otherwise identical (having the same ring size and type and number of atoms in the main ring) but lacking a superstructure (especially linking moieties or, preferably cross-bridging moieties) found in the MRL's.
• parent macrocycle which is otherwise identical (having the same ring size and type and number of atoms in the main ring) but lacking a superstructure (especially linking moieties or, preferably cross-bridging moieties) found in the MRL's.
• the practitioner will use the free form (not the metal-bound form) of the macrocycles.
• Rigidity is well-known to be useful in comparing macrocycles; suitable tools for determining, measuring or comparing rigidity include computational methods (see, for example, Zimmer, Chemical Reviews. (1995), 95(38), 2629-2648 or Hancock et al., Inorganica Chimica Acta. (1989). 164,
• Preferred MRL's herein are a special type of ultra-rigid ligand which is cross-bridged.
• cross-bridge is nonlimitingly illustrated in 1.11 hereinbelow. In 1.1 1 , the cross-bridge is a -
• Suitable metals in the rigid ligand complexes include Mn(II), Mn(III), Mn(IV), Mn(V), Fe(II), Fe(III), Fe(IV), Co(I), Co(II), Co(III), Ni(I), Ni(II), Ni(III), Cu(I), Cu(II), Cu(III),Cr(II), Cr(III), Cr(IV), Cr(V), Cr(VI), V(III), V(IV), V(V), Mo(IV), Mo(V), Mo(VI), W(IV), W(V), W(VI), Pd(II), Ru(II), Ru(III), and Ru(IV).
• Preferred transition-metals in the instant transition- metal bleach catalyst include manganese, iron and chromium.
• the MRL's (and the corresponding transition-metal catalysts) herein suitably comprise: V
• a covalently connected non-metal superstructure capable of increasing the rigidity of the macrocycle, preferably selected from
• a bridging superstructure such as a linking moiety
• a cross-bridging superstructure such as a cross-bridging linking moiety
• superstructure is used herein as defined in the literature by Busch et al., see, for example, articles by Busch in "Chemical Reviews”.
• Preferred superstructures herein not only enhance the rigidity of the parent macrocycle, but also favor folding of the macrocycle so that it co-ordinates to a metal in a cleft.
• Suitable superstructures can be remarkably simple, for example a linking moiety such as any of those illustrated in Fig. 1 and Fig. 2 below, can be used.
• n is an integer, for example from 2 to 8, preferably less than 6, typically 2 to 4, or
• Fig. 2 wherein m and n are integers from about 1 to 8, more preferably from 1 to 3; Z is N or CH; and T is a compatible substituent, for example H, alkyl, trialkylammonium, halogen, nitro, sulfonate, or the like.
• the aromatic ring in 1.10 can be replaced by a saturated ring, in which the atom in Z connecting into the ring can contain N, O, S or C.
• Suitable MRL's are further nonlimitingly illustrated by the following compound:
• Fig. 3 This is a MRL in accordance with the invention which is a highly preferred, cross- bridged, methyl-substituted (all nitrogen atoms tertiary) derivative ofcyclam.
• this ligand is named 5,12-dimethyl-l,5,8,12-tetraazabicyclo[6.6.2J ⁇ exadecane using the extended von Baeyer system. See "A Guide to IUPAC Nomenclature of Organic Compounds: Recommendations 1993", R. Panico, W.H. Powell and J-C Richer (Eds.), Blackwell Scientific Publications, Boston, 1993; see especially section R-2.4.2.1.
• Transition-metal bleach catalysts of Macrocyclic Rigid Ligands which are suitable for use in the invention compositions can in general include known compounds where they conform with the definition herein, as well as, more preferably, any of a large number of novel compounds expressly designed for the present laundry or cleaning uses, and non-limitingly illustrated by any of the following:
• compositions and cleaning processes herein can be adjusted to provide on the order of at least one part per hundred million of the active bleach catalyst species in the aqueous washing medium, and will preferably provide from about 0.01 ppm to about 25 ppm, more preferably from about 0.05 ppm to about 10 ppm, and most preferably from about 0.1 ppm to about 5 ppm, of the bleach catalyst species in the wash liquor.
• typical compositions herein will comprise from about 0.0005% to about 0.2%, more preferably from about 0.004% to about 0.08%, of bleach catalyst, especially manganese or cobalt catalysts, by weight of the cleaning compositions.
• adjunct ingredients useful in the laundry compositions of the present invention
• said adjunct ingredients include builders, optical brighteners, soil release polymers, dye transfer agents, dispersents, enzymes, suds suppressers, dyes, perfumes, colorants, filler salts, hydrotropes, photoactivators, fluorescers, fabric conditioners, hydrolyzable surfactants, preservatives, anti-oxidants, chelants, stabilizers, anti- shrinkage agents, anti-wrinkle agents, germicides, fungicides, anti corrosion agents, and mixtures thereof.
• the laundry detergent compositions of the present invention preferably comprise one or more detergent builders or builder systems.
• the compositions will typically comprise at least about 1% builder, preferably from about 5%, more preferably from about 10% to about 80%, preferably to about 50%, more preferably to about 30% by weight, of detergent builder.
• the level of builder can vary widely depending upon the end use of the composition and its desired physical form. When present, the compositions will typically comprise at least about 1% builder. Formulations typically comprise from about 5% to about 50%, more typically about 5% to about 30%, by weight, of detergent builder. Granular formulations typically comprise from about 10% to about 80%, more typically from about 15% to about 50% by weight, of the detergent builder. Lower or higher levels of builder, however, are not meant to be excluded.
• Inorganic or P-containing detergent builders include, but are not limited to, the alkali metal, ammonium and alkanolammonium salts of polyphosphates (exemplified by the tripolyphosphates, pyrophosphates, and glassy polymeric meta-phosphates), phosphonates, phytic acid, silicates, carbonates (including bicarbonates and sesquicarbonates), sulphates, and aluminosilicates.
• non-phosphate builders are required in some locales.
• compositions herein function surprisingly well even in the presence of the so-called “weak” builders (as compared with phosphates) such as citrate, or in the so-called “underbuilt” situation that may occur with zeolite or layered silicate builders.
• silicate builders are the alkali metal silicates, particularly those having a Si ⁇ 2:Na2 ⁇ ratio in the range 1.6:1 to 3.2:1 and layered silicates, such as the layered sodium silicates described in U.S. 4,664,839 Rieck, issued May 12, 1987.
• NaSKS-6 is the trademark for a crystalline layered silicate marketed by Hoechst (commonly abbreviated herein as "SKS-6").
• Hoechst commonly abbreviated herein as "SKS-6”
• the Na SKS-6 silicate builder does not contain aluminum.
• NaSKS-6 has the delta-Na2Si ⁇ 5 morphology form of layered silicate.
• SKS-6 is a highly preferred layered silicate for use herein, but other such layered silicates, such as those having the general formula NaMSi x ⁇ 2 x + ⁇ y ⁇ O wherein M is sodium or hydrogen, x is a number from 1.9 to 4, preferably 2, and y is a number from 0 to 20, preferably 0 can be used herein.
• Various other layered silicates from Hoechst include NaSKS-5, NaSKS-7 and NaSKS-11, as the alpha, beta and gamma forms.
• delta-Na2Si ⁇ 5 (NaSKS-6 form) is most preferred for use herein.
• Other silicates may also be useful such as for example magnesium silicate, which can serve as a crispening agent in granular formulations, as a stabilizing agent for oxygen bleaches, and as a component of suds control systems.
• carbonate builders are the alkaline earth and alkali metal carbonates as disclosed in German Patent Application No. 2,321,001 published on November 15, 1973.
• Aluminosilicate builders are useful in the present invention. Aluminosilicate builders are of great importance in most currently marketed heavy duty granular detergent compositions, and can also be a significant builder ingredient in liquid detergent formulations. Aluminosilicate builders include those having the empirical formula:
• aluminosilicate ion exchange materials are commercially available. These aluminosilicates can be crystalline or amorphous in structure and can be naturally-occurring aluminosilicates or synthetically derived. A method for producing aluminosilicate ion exchange materials is disclosed in U.S. 3,985,669, Krummel et al, issued October 12, 1976. Preferred synthetic crystalline aluminosilicate ion exchange materials useful herein are available under the designations Zeolite A, Zeolite P (B), Zeolite MAP and Zeolite X. In an especially preferred embodiment, the crystalline aluminosilicate ion exchange material has the formula:
• This material is known as Zeolite A.
• the aluminosilicate has a particle size of about 0.1-10 microns in diameter.
• Organic detergent builders suitable for the, purposes of the present invention include, but are not restricted to, a wide variety of polycarboxylate compounds.
• poly- carboxylate refers to compounds having a plurality of carboxylate groups, preferably at least 3 carboxylates.
• Polycarboxylate builder can generally be added to the composition in acid form, but can also be added in the form of a neutralized salt. When utilized in salt form, alkali metals, such as sodium, potassium, and lithium, or alkanolammonium salts are preferred.
• polycarboxylate builders include a variety of categories of useful materials.
• One important category of polycarboxylate builders encompasses the ether polycarboxy- lates, including oxydisuccinate, as disclosed in U.S. 3,128,287 Berg, issued April 7, 1964, U.S. 3,635,830 Lamberti et al., issued January 18, 1972, and U.S. 3,936,448 Lamberti, issued February 3, 1976. See also "TMS/TDS" builders of U.S. 4,663,071 Bush et al., issued May 5, 1987.
• Suitable ether polycarboxylates also include cyclic compounds, particularly alicyclic compounds, such as those described in U.S.
• ether hydroxypolycarboxylates copoly- mers of maleic anhydride with ethylene or vinyl methyl ether, 1, 3, 5-trihydroxy benzene-2, 4, 6- trisulphonic acid, and carboxymethyloxysuccinic acid
• various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid
• polycarboxylates such as mellitic acid, succinic acid, oxy- disuccinic acid, polymaleic acid, benzene 1,3,5-tricarboxylic acid, carboxymethyloxysuccinic acid, and soluble salts thereof.
• Citrate builders e.g., citric acid and soluble salts thereof (particularly sodium salt), are polycarboxylate builders of particular importance for heavy duty liquid detergent formulations due to their availability from renewable resources and their biodegradability. Citrates can also be used in granular compositions, especially in combination with zeolite and/or layered silicate builders. Oxydisuccinates are also especially useful in such compositions and combinations.
• succinic acid builders include the C5-C20 alkyl and alkenyl succinic acids and salts thereof. A particularly preferred compound of this type is do- decenylsuccinic acid.
• succinate builders include: laurylsuccinate, myristylsuccinate, palmitylsuccinate, 2-dodecenylsuccinate (preferred), 2-pentadecenylsucci- nate, and the like. Laurylsuccinates are the preferred builders of this group, and are described in European Patent Application 86200690.5/0,200,263, published November 5, 1986.
• Fatty acids e.g., C ⁇ -Cj g monocarboxylic acids
• Such use of fatty acids will generally result in a diminution of sudsing, which should be taken into account by the formulator.
• the various alkali metal phosphates such as the well-known sodium tripolyphosphates, sodium pyrophosphate and sodium orthophosphate can be used.
• Phosphonate builders such as ethane- 1 -hydroxy- 1 , 1 -diphosphonate and other known phosphonates (see, for example, U.S. Patents 3,159,581 ; 3,213,030; 3,422,021 ; 3,400,148 and 3,422,137) can also be used.
• the detergent compositions herein may also optionally contain one or more iron and/or manganese chelating agents.
• chelating agents can be selected from the group consisting of amino carboxylates, amino phosphonates, polyfunctionally-substituted aromatic chelating agents and mixtures therein, all as hereinafter defined. Without intending to be bound by theory, it is believed that the benefit of these materials is due in part to their exceptional ability to remove iron and manganese ions from washing solutions by formation of soluble chelates.
• EDDS ethylenediamine disuccinate
• [S,S] isomer as described in U.S. Patent 4,704,233, November 3, 1987, to Hartman and Perkins.
• compositions herein may also contain water-soluble methyl glycine diacetic acid (MGDA) salts (or acid form) as a chelant or co-builder useful with, for example, insoluble builders such as zeolites, layered silicates and the like.
• MGDA water-soluble methyl glycine diacetic acid
• these chelating agents will generally comprise from about 0.1% by weight of the detergent compositions herein to about 15%, more preferably 3.0% by weight of the detergent compositions herein.
• the detergent compositions of the present invention may also include one or more compounds, dye transfer inhibiting agents, for inhibiting dye transfer from one fabric to another of solubilized and suspended dyes encountered during fabric laundering and conditioning operations involving colored fabrics.
• Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. Examples of such dye transfer inhibiting agents are disclosed in U.S. Pat. Nos. 5,707,950 and 5,707,951.
• Additional suitable dye transfer inhibiting agents include, but are not limited to, cross- linked polymers.
• Cross-linked polymers are polymers whose backbone are interconnected to a certain degree; these links can be of chemical or physical nature, possibly with active groups on the backbone or on branches. Cross-linked polymers have been described in the Journal of Polymer Science, volume 22, pages 1035-1039.
• the cross-linked polymers are made in such a way that they form a three-dimensional rigid structure, which can entrap dyes in the pores formed by the three- dimensional structure.
• the cross-linked polymers entrap dyes by swelling.
• Suitable cross-linked polymers are described in the co-pending European patent application 94870213.9.
• the dye transfer inhibiting agents have the ability to complex or adsorb fugitive dyes wash out of dyed fabrics before the dyes have the opportunity to become attached to other articles in the wash.
• the dye transfer inhibiting agents are present at levels from about 0.0001%, more preferably about 0.01%), most preferably about 0.05%o by weight of the detergent compositions to about 10%, more preferably about 2%, most preferably about 1% by weight of the detergent compositions.
• Dispersants are present at levels from about 0.0001%, more preferably about 0.01%), most preferably about 0.05%o by weight of the detergent compositions to about 10%, more preferably about 2%, most preferably about 1% by weight of the detergent compositions.
• the detergent composition of the present invention can also contain dispersants.
• Suitable water-soluble organic salts are the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
• Polymers of this type are disclosed in GB-A- 1,596,756.
• Examples of such salts are polyacrylates of MW 2000-5000 and their copolymers with maleic anhydride, such copolymers having a molecular weight of from 1 ,000 to 100,000.
• copolymer of acrylate and methylacrylate such as the 480N having a molecular weight of 4000, at a level from 0.5-20% by weight of composition can be added in the detergentcompositions of the present invention.
• compositions of the invention may contain a lime soap peptiser compound, which has a lime soap dispersing power (LSDP), as defined hereinafter of no more than 8, preferably no more than 7, most preferably no more than 6.
• LSDP lime soap dispersing power
• the lime soap peptiser compound is preferably present at a level from 0% to 20% by weight.
• LSDP lime soap dispersant power
• Surfactants having good lime soap peptiser capability will include certain amine oxides, betaines, sulfobetaines, alkyl ethoxysulfates and ethoxylated alcohols.
• Hydrophobic bleaches such as 4-[N-octanoyl-6-aminohexanoyl]benzene sulfonate, 4- [N-nonanoyl-6-aminohexanoyl]benzene sulfonate, 4-[N-decanoyl-6-aminohexanoyl]benzene sulfonate and mixtures thereof; and nonanoyloxy benzene sulfonate together with hydrophilic / hydrophobic bleach formulations can also be used as lime soap peptisers compounds.
• the detergent compositions can comprise in addition to the amylase of the present invention one or more detergent enzymes which provide cleaning performance and/or fabric care benefits.
• Such enzymes can include proteases, amylases, cellulases and upases.
• Such materials are known in the art and are commercially available under such trademarks as . They may be incorporated into the non-aqueous liquid detergent compositions herein in the form of suspensions, "marumes" or "prills".
• Another suitable type of enzyme comprises those in the form of slurries of enzymes in nonionic surfactants, e.g., the enzymes marketed by Novo Nordisk under the tradename "SL” or the microencapsulated enzymes marketed by Novo Nordisk under the tradename "LDP.” Suitable enzymes and levels of use are described in U.S. Pat. No. 5,576,282.
• Enzymes added to the compositions herein in the form of conventional enzyme prills are especially preferred for use herein.
• Such prills will generally range in size from about 100 to 1,000 microns, more preferably from about 200 to 800 microns and will be suspended throughout the non-aqueous liquid phase of the composition.
• Prills in the compositions of the present invention have been found, in comparison with other enzyme forms, to exhibit especially desirable enzyme stability in terms of retention of enzymatic activity over time.
• compositions which utilize enzyme prills need not contain conventional enzyme stabilizing such as must frequently be used when enzymes are incorporated into aqueous liquid detergents.
• suitable enzymes include, but are not limited to, hemicellulases, peroxidases, proteases, cellulases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, keratanases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, malanases, ⁇ -glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, and known amylases, or mixtures thereof.
• a preferred combination is a detergent composition having a cocktail of conventional applicable enzymes like protease, lipase, cutinase and/or cellulase in conjunction with the amylase of the present invention.
• Suitable proteases are the subtilisins which are obtained from particular strains of B. subtilis and B. licheniformis (subtilisin BPN and BPN').
• One suitable protease is obtained from a strain of Bacillus, having maximum activity throughout the pH range of 8-12, developed and sold as ESPERASE® by Novo Industries A/S of Denmark, hereinafter "Novo". The preparation of this enzyme and analogous enzymes is described in GB 1,243,784 to Novo.
• Other suitable proteases include ALCALASE®, DURAZYM® and SAVINASE® from Novo and MAXATASE®, MAXACAL®, PROPERASE® and MAXAPEM® (protein engineered Maxacal) from Gist-Brocades.
• Proteolytic enzymes also encompass modified bacterial serine proteases, such as those described in European Patent Application Serial Number 87 303761.8, filed April 28, 1987 (particularly pages 17, 24 and 98), and which is called herein "Protease B", and in European Patent Application 199,404, Venegas, published October 29, 1986, which refers to a modified bacterial serine protealytic enzyme which is called "Protease A” herein.
• Protease C is a variant of an alkaline serine protease from Bacillus in which lysine replaced arginine at position 27, tyrosine replaced valine at position 104, serine replaced asparagine at position 123, and alanine replaced threonine at position 274.
• Protease C is described in EP 90915958:4, corresponding to WO 91/06637, Published May 16, 1991. Genetically modified variants, particularly of Protease C, are also included herein. See also a high pH protease from Bacillus sp. NCIMB 40338 described in WO 93/18140 A to Novo.
• Enzymatic detergents comprising protease, one or more other enzymes, and a reversible protease inhibitor are described in WO 92/03529 A to Novo.
• a protease having decreased adsorption and increased hydrolysis is available as described in WO 95/07791 to Procter & Gamble.
• a recombinant trypsin-like protease for detergents suitable herein is described in WO 94/25583 to Novo.
• protease referred to as "Protease D” is a carbonyl hydrolase variant having an amino acid sequence not found in nature, which is derived from a precursor carbonyl hydrolase by substituting a different amino acid for a plurality of amino acid residues at a position in said carbonyl hydrolase equivalent to position +76, preferably also in combination with one or more amino acid residue positions equivalent to those selected from the group consisting of +99, +101, +103, +104, +107, +123, +27, +105, +109, +126, +128, +135, +156, +166, +195, +197, +204, +206, +210, +216, +217, +218, +222, +260, +265, and/or +274 according to the numbering of Bacillus amyloliquefaciens subtilisin, as described in WO 95/10615 published April 20, 1995 by Genencor International.
• proteases described in patent applications EP 251 446 and WO91/06637 and protease BLAP® described in W091/02792.
• the proteolytic enzymes are incorporated in the detergent compositions of the present invention a level of from 0.0001% to 2%, preferably from 0.001%) to 0.2%, more preferably from 0.005%) to 0.1% pure enzyme by weight of the composition.
• proteases are also described in PCT publications: WO 95/30010 published November 9, 1995 by The Procter & Gamble Company; WO 95/30011 published November 9, 1995 by The Procter & Gamble Company; WO 95/29979 published November 9, 1995 by The Procter & Gamble Company.
• the cellulases usable in the present invention include both bacterial or fungal cellulase. Preferably, they will have a pH optimum of between 5 and 9.5. Suitable cellulases are disclosed in U.S. Patent 4,435,307, Barbesgoard et al, which discloses fungal cellulase produced from Humicola insolens. Suitable cellulases are also disclosed in GB-A-2.075.028; GB-A-2.095.275 and DE-OS-2.247.832.
• cellulases examples include cellulases produced by a strain of Humicola insolens (Humicola grisea var. thermoidea), particularly the Humicola strain DSM 1800.
• Other suitable cellulases are cellulases originated from Humicola insolens having a molecular weight of about 50KDa, an isoelectric point of 5.5 and containing 415 amino acids; and a ⁇ 43kD endoglucanase derived from Humicola insolens, DSM 1800, exhibiting cellulase activity; a preferred endoglucanase component has the amino acid sequence disclosed in PCT Patent Application No. WO 91/17243.
• suitable cellulases are the EGIII cellulases from Trichoderma longibrachiatum described in WO94/21801, Genencor, published September 29, 1994. Especially suitable cellulases are the cellulases having color care benefits. Examples of such cellulases are cellulases described in European patent application No. 91202879.2, filed November 6, 1991 (Novo). Carezyme and Celluzyme (Novo Nordisk A/S) are especially useful. See also W091/17243.
• Peroxidase enzymes are known in the art, and include, for example, horseradish peroxidase, ligninase and haloperoxidase such as chloro- and bromo-peroxidase.
• Peroxidase- containing detergent compositions are disclosed, for example, in U.S. Patent Nos. 5,576,282, 5,728,671 and 5,707,950, PCT International Applications WO 89/099813, WO89/09813 and in European Patent application EP No. 91202882.6, filed on November 6, 1991 and EP No. 96870013.8, filed February 20, 1996.
• laccase enzyme is also suitable for the laccase enzyme.
• Preferred enhancers are substitued phenthiazine and phenoxasine 10- Phenothiazinepropionicacid (PPT), 10-ethylphenothiazine-4-carboxylic acid (EPC), 10- phenoxazinepropionic acid (POP) and 10-methylphenoxazine (described in WO 94/12621) and substitued syringates (C3-C5 substitued alkyl syringates) and phenols.
• Sodium percarbonate or perborate are preferred sources of hydrogen peroxide.
• Said peroxidases are normally incorporated in the detergent composition at levels from 0.0001% to 2% of active enzyme by weight of the detergent composition.
• Suitable lipase enzymes for detergent usage include those produced by microorganisms of the Pseudomonas group, such as Pseudomonas stutzeri ATCC 19.154, as disclosed in British Patent 1,372,034.
• Suitable lipases include those which show a positive immunological cross-reaction with the antibody of the lipase, produced by the microorganism Pseudomonas fluorescent IAM 1057. This lipase is available from Amano Pharmaceutical Co. Ltd., Nagoya, Japan, under the trade name Lipase P "Amano,” hereinafter referred to as "Amano-P".
• lipases include Amano-CES, lipases ex Chromobacter viscosum, e.g. Chromobacter viscosum var. lipolyticum NRRLB 3673 from Toyo Jozo Co., Tagata, Japan; Chromobacter viscosum lipases from U.S. Biochemical Corp., U.S.A. and Disoynth Co., The Netherlands, and lipases ex Pseudomonas gladioli.
• lipases such as Ml LIPASE® and LIPOMAX® (Gist-Brocades) and LIPOLASE® and LIPOLASE ULTRA®(Novo) which have found to be very effective when used in combination with the compositions of the present invention.
• cutinases [EC 3.1.1.50] which can be considered as a special kind of lipase, namely lipases which do not require interfacial activation. Addition of cutinases to detergent compositions have been described in e.g. WO 88/09367 (Genencor).
• the lipases and/or cutinases are normally incorporated in the detergent composition at levels from 0.0001% to 2% of active enzyme by weight of the detergent composition.
• amylases can be included for removal of carbohydrate-based stains.
• WO 94/02597 Novo Nordisk A/S published February 03, 1994, describes cleaning compositions which incorporate mutant amylases. See also W094/18314, Genencor, published August 18, 1994 and WO95/10603, Novo Nordisk A/S, published April 20, 1995.
• Other amylases known for use in detergent compositions include both ⁇ - and ⁇ -amylases.
• ⁇ -Amylases are known in the art and include those disclosed in US Pat.
• amylases including PURAFACT OX AM® described in WO 94/18314, published August 18, 1994 and WO96/05295, Genencor, published Februaury 22, 1996 and amylase variants from Novo Nordisk A/S, disclosed in WO 95/10603, published April 95.
• ⁇ -amylases examples include TERMAMYL®, BAN®, FUNGAMYL® and DURAMYL®, all available from Novo Nordisk A/S Denmark.
• WO95/26397 describes other suitable amylases : ⁇ -amylases characterized by having a specific activity at least 25% higher than the specific activity of TERMAMYL® at a temperature range of 25°C to 55°C and at a pH value in the range of 8 to 10, measured by the Phadebas® ⁇ - amylase activity assay.
• Other amylolytic enzymes with improved properties with respect to the activity level and the combination of thermostability and a higher activity level are described in WO95/35382.
• the above-mentioned enzymes may be of any suitable origin, such as vegetable, animal, bacterial, fungal and yeast origin. Purified or non-purified forms of these enzymes may be used. Also included by definition, are mutants of native enzymes. Mutants can be obtained e.g. by protein and/or genetic engineering, chemical and/or physical modifications of native enzymes. Common practice as well is the expression of the enzyme via host organisms in which the genetic material responsible for the production of the enzyme has been cloned.
• Said enzymes are normally incorporated in the detergent composition at levels from 0.0001% to 2% of active enzyme by weight of the detergent composition.
• the enzymes can be added as separate single ingredients (prills, granulates, stabilized liquids, etc. containing one enzyme ) or as mixtures of two or more enzymes ( e.g.cogranulates).
• enzyme oxidation scavengers are ethoxylated tetraethylene polyamines.
• a range of enzyme materials and means for their incorporation into synthetic detergent compositions is also disclosed in WO 93/07263 and WO 93/07260 to Genencor International, WO 89/08694 to Novo, and U.S. 3,553,139, January 5, 1971 to McCarty et al. Enzymes are further disclosed in U.S. 4,101,457, Place et al, July 18, 1978, and in U.S. 4,507,219, Hughes, March 26, 1985. Enzyme materials useful for liquid detergent formulations, and their incorporation into such formulations, are disclosed in U.S. 4,261,868, Hora et al, April 14, 1981. Enzyme Stabilizers
• Enzymes for use in detergents can be stabilized by various techniques. Enzyme stabilization techniques are disclosed and exemplified in U.S. 3,600,319, August 17, 1971, Gedge et al, EP 199,405 and EP 200,586, October 29, 1986, Venegas. Enzyme stabilization systems are also described, for example, in U.S. 3,519,570. A useful Bacillus, sp. AC13 giving proteases, xylanases and cellulases, is described in WO 9401532 to Novo. The enzymes employed herein can be stabilized by the presence of water-soluble sources of calcium and/or magnesium ions in the finished compositions which provide such ions to the enzymes. Suitable enzyme stabilizers and levels of use are described in U.S. Pat. No. 5,576,282. Other Detergent Ingredients
• the detergent compositions herein may also optionally contain one or more of the following: polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids and/or pigments. Suitable examples of such other detergent ingredients and levels of use are found in U.S. Patent No. 5,576,282. Method of washing
• compositions of the invention may be used in essentially any washing or cleaning methods, including soaking methods, pretreatment methods and methods with rinsing steps for which a separate rinse aid composition may be added.
• the process described herein comprises contacting fabrics with a laundering solution in the usual manner and exemplified hereunder.
• the process of the invention is conveniently carried out in the course of the cleaning process.
• the method of cleaning is preferably carried out at 5°C to 95°C, especially between 10°C and 60°C.
• the pH of the treatment solution is preferably from 7 to 1 1.
• compositions of the present invention are meant to exemplify compositions of the present invention, but are not necessarily meant to limit or otherwise define the scope of the invention.
• the enzyme levels are expressed by pure enzyme by weight of the total composition and unless otherwise specified, the detergent ingredients are expressed by weight of the total compositions.
• the abbreviated component identifications herein have the following meanings: LAS : Sodium linear Cj2 alkyl benzene sulphonate
• Ci2-Cj5 predominantly linear primary alcohol condensed with an average of Y moles of ethylene oxide
• Neodol 45-13 C14-C15 linear primary alcohol ethoxylate sold by Shell Chemical CO.
• Carbonate Anhydrous sodium carbonate with a particle size between 200 ⁇ m and 900 ⁇ m.
• Bicarbonate Anhydrous sodium bicarbonate with a particle size between 400 ⁇ m and 1200 ⁇ m.
• NOBS Nonanoyloxybenzene sulfonate in the form of the sodium salt.
• Photoactivated Bleach Sulfonated zinc phtalocyanine encapsulated in dextrin soluble polymer.
• Protease Proteolytic enzyme sold under the tradename Savinase, Alcalase, Durazym by Novo Nordisk A/S, Maxacal, Maxapem sold by Gist-Brocades and proteases described in patents W091/06637 and/or WO95/10591 and/or EP 251,446.
• Amylase Amylolytic enzyme prepared by the present invention method having hydrolytic activity 50% faster than that of the amylase enzyme having SEQ. ID. 1.
• Lipase Lipolytic enzyme sold under the tradename Lipolase, Lipolase Ultra by Novo Nordisk A/S
• DETPMP Diethylene triamine penta (methylene phosphonic acid), marketed by Monsanto under the Trade name Dequest 2060.
• Brightener 1 Disodium 4,4'-bis(2-sulphostyryl)biphenyl.
• Brightener 2 Disodium 4,4'-bis(4-anilino-6-morpholino- 1.3.5-triazin-2-yl) stilbene-2:2'-disulfonate.
• SRP 1 Sulfobenzoyl or sodium isethionate end capped esters with oxyethylene oxy and terephtaloyl backbone.
• SRP 2 Diethoxylated poly ( 1 ,2 propylene terephtalate) short block polymer.
• Sulphate Anhydrous sodium sulphate.
• HMWPEO High molecular weight polyethylene oxide
• liquid detergent formulations > according to the present invention are prepared:
• Granular fabric detergent compositions which provide "softening through the wash” capability are prepared in accord with the present invention :
• Granular suds suppressor 1.0 4.0 CMC 0.2 0.1 Water/minors Up to 100%
• Syndet bar fabric detergent compositions are prepared in accord with the present invention :
• amylase of the present invention can be formulated into any suitable laundry detergent composition, non-limiting examples of which are described in U.S. 5,679,630 Baeck et al., issued October 21, 1997; U.S. 5,565,145 Watson et al., issued October 15, 1996; U.S. 5,478,489 Fredj et al., issued December 26, 1995; U.S. 5,470,507 Fredj et al., issued November 28, 1995; U.S. 5,466,802 Panandiker et al., issued November 14, 1995; U.S. 5,460,752 Fredj et al., issued October 24, 1995; U.S. 5,458,810 Fredj et al., issued October 17, 1995; U.S. 5,458,809 Fredj et al., issued October 17, 1995; U.S. 5,288,431 Huber et al., issued February 22, 1994 all of which are incorporated herein by reference.
• compositions of the present invention can be suitably prepared by any process chosen by the formulator, non-limiting examples of which are described in U.S. 5,691,297 Nassano et al., issued November 11, 1997; U.S. 5,574,005 Welch et al., issued November 12, 1996; U.S. 5,569,645 Dinniwell et al., issued October 29, 1996; U.S. 5,565,422 Del Greco et al., issued October 15, 1996; U.S. 5,516,448 Capeci et al., issued May 14, 1996; U.S. 5,489,392 Capeci et al., issued February 6, 1996; U.S. 5,486,303 Capeci et al., issued January 23, 1996 all of which are incorporated herein by reference.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Genetics & Genomics (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Molecular Biology (AREA)
• Microbiology (AREA)
• Biotechnology (AREA)
• Biomedical Technology (AREA)
• Biochemistry (AREA)
• General Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Detergent Compositions (AREA)
• Enzymes And Modification Thereof (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=22041387

Family Applications (1)

Country Status (6)

Families Citing this family (11)

Family Cites Families (3)

• 1998
  • 1998-10-14 CA CA002307324A patent/CA2307324A1/en not_active Abandoned
  • 1998-10-14 EP EP98946634A patent/EP1023448A1/de not_active Withdrawn
  • 1998-10-14 JP JP2000517088A patent/JP2001520043A/ja not_active Withdrawn
  • 1998-10-14 WO PCT/IB1998/001615 patent/WO1999020768A1/en not_active Application Discontinuation
  • 1998-10-14 CN CN 98812281 patent/CN1282373A/zh active Pending
  • 1998-10-14 BR BR9813865-0A patent/BR9813865A/pt not_active IP Right Cessation

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events